期刊文献+

初诊2型糖尿病血糖控制与C反应蛋白相关性探讨

STUDY ON THE RELATIONSHIP BETWEEN BLOOD GLUCOSE CONTROL AND SERUM C-REACTIVE PROTEIN LEVEL IN NEWLY ONSET PATIENTS WITH NIDDM
下载PDF
导出
摘要 目的探讨2型糖尿病患者血糖控制与血清c反应蛋白(CRP)变化的相关性。方法选初诊断为T2DM患者90倒,另选同时期在我院体检的健康人群90人作为对照纽,并按性别、年龄、体重与实验纽进行对照匹配,治疗前后检查治疗组与对照组的身高、体重,空腹血糖(FPG)、空腹胰岛素(Fins)、总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白(HDL—C)、低密度脂蛋白(LDL—C)、糖化血红蛋白(HbAlc)以及C反应蛋白(CRP)。结果治疗前治疗组CRP明显高于对照组;治疗后治疗组CRP与对照组无明显差异。CRP水平与血糖水平呈正相关。结论2型糖尿病的发生与发展可能与机体的慢性炎症反应相关,部分体现在血清CRP的升高,在今后对2型糖尿病的诊治中要密切关注患者血清CRP的水平,早期使用胰岛素治疗可能有助于减轻炎症反应,延缓病程。 Objective To investigate the relationship between blood glucose control and the change of serum C - reactive protein (CRP) in patients with NIDDM. Methods 90 newly onset NIDDM patients in our hospital were chosen to be control group and 90 health peoples were assigned to be contrast group matched by gender, age and body weight. The body height, body weight, fasting plasma glucose (FPG), fasting insulin (Fins), total cholesterol (TC), triglycefide (TG), high density lipoprotein (HDL), low density lipoprotein (LDL), glycosylated hemoglobin (HbAlc), and C -reactive protein (CRP) were detected. Resttlts The level of CRP in the control group was sig- nificantly higher than that in the contrast group pretherapy. There was no noticeable difference in CRP level between two groups post - treatment. The level of CRP in NIDDM patients was positive correlated with blood glucose. Conclu- sion The nosogenesis of NIDDM may be related to the chronic inflammatory reaction with high serum CRP level. We should pay close attention to the change of serum CRP level in patients with NIDDM during the treatment, and the early application of insulin may be helpful to reduce inflammatory reaction and delay the course of NIDDM.
作者 陈国威
机构地区 东莞市莞城医院
出处 《现代医院》 2010年第7期21-23,共3页 Modern Hospitals
关键词 2型糖尿病 胰岛素 C反应蛋白 强化治疗 NIDDM, Insulin, C- reactive protein, Intensification therapy
  • 相关文献

参考文献12

  • 1孙涛 李向东 杨文东.2型糖尿病患者血清IL-6、hs-CRP及APN水平变化及其相关性.医学检验与临床,2009,20(1):10-13.
  • 2阮丹杰,王伟.炎性因子与胰岛素抵抗的研究进展[J].医学综述,2009,15(4):508-511. 被引量:30
  • 3胡兆霆,吕艳青,陈幼明.代谢综合征患者胰岛素抵抗与炎症反应标记物的相关性研究,2006,6(6):616-618.
  • 4张弢,白然,张寒,刘加和,杨郁,巴颖,孙国华,孙丽鹏,杜建玲,李昌臣.短病程2型糖尿病患者C反应蛋白与血糖控制的相关性[J].中国糖尿病杂志,2006,14(5):372-373. 被引量:6
  • 5张秀薇,祁志云,黄秋霞,陈伟坤,孙晓玲,孙庆凯,陈丹.2型糖尿病患者C反应蛋白水平与代谢综合征的关系[J].医师进修杂志,2005,28(8):20-22. 被引量:5
  • 6VOLANAKIS J E.Human C-reactive protein:expression,structure and function[J].Mollmmunol,2001,38:189-97.
  • 7FESTA A D,AGOSTINO RJR,HOWARD G,et al.Elevated levels of acute phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes:the insulin resistance atherosclerosis study[J].Diabetes,2002.51:1311-1137.
  • 8RIDKER P M,RIFAI N,LOWENTHAL S P.Rapid relation of C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolcmia[J].Circulation,2001,103:1191-1193.
  • 9朱本章,马卫国,南佳彦.胰岛素抗炎作用的研究及应用进展[J].中国实用内科杂志,2006,26(9):1309-1311. 被引量:25
  • 10DANA E,ARCH G,THOMAS A,et al.C-reactive protein and glycemic control in adults with diabetes[J].Diabetes Care,2003,26:1535-1539.

二级参考文献28

  • 1顾卫琼,陈名道,顾元骏,唐金凤,孙首悦,刘长勤,洪洁,张翼飞,李小英,宁光.脂联素受体在胰岛细胞表达,脂联素促进胰岛素的分泌[J].中华内分泌代谢杂志,2005,21(1):68-70. 被引量:34
  • 2陈新龙,夏照帆,韦多,贲道锋,唐洪泰,葛绳德.c-Jun氨基末端激酶抑制剂减轻烫伤后胰岛素抵抗的实验研究[J].中华烧伤杂志,2006,22(6):466-468. 被引量:6
  • 3Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly:the cardiovascular health study. Diabetes,2001,50(10) :2 384 - 2 389.
  • 4Festst A,D'Agostino R JR, Howard G, et al. Chronic subclinical inflammation asart of the insulin resistance syndrome. Circulation, 2000, 102 (1):42-47.
  • 5Spranger J, Kroke A, Mohig M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: result of the prospective populationbased european prospective investigation into cancer and nutrition (EPIC) - potsdam study. Dabetes,2003, 52(3) :812 - 817.
  • 6Pikup JC, Crook MA. Is type 2 diabetes mellitus a disease of the innate immune system? Diabetolohia, 1998,41:1 241 - 1 248.
  • 7Stem MP.Diabetes and cardiovascular diseasethe "commom soil" hypothesis. Diabetes, 1995,44:369 - 374.
  • 8Duncan BB, Schmidt MI. Chronic activation of the innate immune system may underlie the metabolic syndrome. Sao Paulo Med J,2001,119(3):122- 127.
  • 9Ridker PM, Rifai N, Rose L, et al. Comparison of C - reactive protein and low- density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N EngJ Med,2002,347:1 557- 1 564.
  • 10Rifai N. Ridker PM. High-sensitivity C-reaction protein: a novel and promising marker of coronary heart disease[J]. Clin Chem, 2001,47:403 - 411.

共引文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部